ALIFUBATINIB – Futibatinib

Futibatinib is listed in the VetinoPharma B2B pharmaceutical product catalog under Oncology. It is commonly referenced in treatment areas related to fgfr2 fusion or rearrangement cholangiocarcinoma reference and should be reviewed for the relevant market, documentation, and intended business context. For wholesale, distribution, or sourcing inquiries, please contact the VetinoPharma team.